Vaccarin Ameliorates Renal Fibrosis by Inhibiting Ferroptosis via Nrf2/SLC7A11/GPX4 Signaling Pathway
Mengjiao Cui,
No information about this author
Qiming Xu,
No information about this author
Lianxiang Duan
No information about this author
et al.
Drug Design Development and Therapy,
Journal Year:
2025,
Volume and Issue:
Volume 19, P. 1609 - 1626
Published: March 1, 2025
Purpose:
Vaccarin
is
a
natural
flavonoid
glycoside
with
anti-inflammatory,
antioxidant
and
nephroprotective
effects.
However,
the
effects
of
vaccarin
on
renal
fibrosis
(RF)
its
molecular
mechanisms
remain
unclear.
This
study
aimed
to
investigate
RF
mechanisms.
Methods:
Network
pharmacology
was
used
analyze
effect
RF,
docking
dynamics
simulations
were
performed
assess
binding
nuclear
factor
erythroid
2-related
2
(Nrf2)
vaccarin.
A
mouse
model
unilateral
ureteral
obstruction
(UUO)
established
in
vivo,
human
tubular
epithelial
(HK2)
cells
induced
transforming
growth
factor-β
(TGF-β)
RSL3,
respectively,
as
an
vitro
model.
The
anti-fibrotic
observed
by
histopathological
staining
determination
fibrous
markers.
Changes
oxidative
stress
ferroptosis-related
markers
detected
kits,
Western
blot
(WB),
qRT-PCR
immunofluorescence
(IF).
Finally,
Nrf2
inhibitors
added
observe
ferroptosis.
Results:
cross
genes
are
enriched
for
stress.
binds
stably
Both
vivo
experiments
showed
that
treatment
reduced
expression
markers,
decreased
levels
reactive
oxygen
species
(ROS),
malondialdehyde
(MDA),
lipid
peroxidation
(LPO)
Fe
2+
,
increased
glutathione
(GSH)
secretion.
In
addition,
down-regulated
Long-chain
acyl-CoA
synthetase
4
(ACSL4),
prostaglandin-endoperoxide
synthase
(PTGS2)
NADPH
oxidase
1
(NOX1),
up-regulated
downstream
solute
transport
family
7
member
11
(SLC7A11)
peroxidase
(GPX4)
expression.
Mechanistic
studies
indicated
activated
Nrf2/SLC7A11/GPX4
pathway
inhibit
ferroptosis,
this
inhibition
effectively
reversed
inhibitor.
Conclusion:
ameliorates
inhibiting
ferroptosis
via
pathway.
Keywords:
vaccarin,
fibrosis,
pathway,
stress,
network
Language: Английский
Prioritization of prognostic biomarkers regulated by calorie restriction in colon cancer through integrated biosignature analysis
Clinical and Experimental Medicine,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: March 20, 2025
Colorectal
cancer
(CRC)
remains
a
critical
global
health
challenge,
ranking
second
in
cancer-related
mortality
and
third
incidence
as
of
2018,
with
risk
increasing
age.
Addressing
its
rising
burden
requires
early
diagnosis,
prognostic
biomarkers,
effective
therapeutic
strategies.
Emerging
evidence
suggests
that
calorie
restriction
may
mitigate
aging-related
functional
decline
influence
CRC
progression,
yet
the
molecular
markers
mechanisms
remain
poorly
understood.
In
this
study,
we
analyzed
GSE24432
dataset,
using
multiple
computational
databases
to
screen
differentially
expressed
genes
(DEGs)
associated
CRC.
Functional
annotations,
including
Gene
Ontology
(GO),
KEGG
pathway
analysis,
gene
set
enrichment
analysis
(GSEA),
were
undertaken
explore
potential
underlying
pathways
pathogenesis.
Kaplan
Meier
Cox
proportional
hazards
regression
analyses
conducted
establish
diagnostic
significance
hub
genes.
The
validation
test
was
via
databases.
Our
investigation
identified
50
DEGs,
cutoff
criteria,
p.
adj
<
0.05,
|log2FC|>
0.3.
GO
results
revealed
extensive
crosstalk
cellular
components
mRNA
ribosome
biogenesis,
AMPK
signaling,
p53
signaling
following
restriction.
To
understand
how
these
DEGs
drive
biological
reactions,
sorted
according
score
>
3
term
obtained
14
most
relevant
terms.
Further
CHORD
showed
are
enriched
biogenesis
protein
synthesis.
(GSEA)
involvement
several
hallmarks,
such
tissue
invasion
metastasis
(p
0.001),
tumor-promoting
inflammation
resisting
cell
death
0.01),
replicative
immortality
0.05).
Survival
higher
expression
7
genes,
CDKN2A
0.05),
RPL9
0.02),
TUBB6
RPS15A
lower
CDKN1B
NPM1
RALA
correlated
shorter
survival
colon
cancer.
However,
cross-reference
decreased
expressions
while
increased
Several
tests
from
high
is
overall
rates,
indicating
target
could
serve
more
reliable
biomarker
for
prognosis.
These
findings
potentially
facilitate
development
precision-based
energy
interventions
management,
offering
promising
prospects
targeted
strategies
patients.
Language: Английский
Magnolia kobus DC. Alleviates adenine-induced chronic kidney disease by regulating ferroptosis in C57BL/6 mice
Jong Min Kim,
No information about this author
Yiseul Kim,
No information about this author
Hyun-Jin Na
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 29, 2025
Magnolia
kobus
DC.
(MO)
is
a
medicinal
plant
that
reportedly
possesses
various
bioactive
properties,
including
anti-hyperplastic,
anti-inflammatory,
and
anti-cancer
effects.
Chronic
kidney
disease
(CKD)
progressive
disorder
characterized
by
inflammation,
fibrosis,
oxidative
stress,
which
leads
to
renal
dysfunction.
This
study
aimed
evaluate
the
renoprotective
effects
of
MO
against
adenine-induced
CKD
in
C57BL/6
mice.
significantly
attenuated
injury
reducing
blood
urea
nitrogen
level
morphological
change.
Additionally,
effectively
reduced
inflammation
inhibiting
expression
tumor
necrosis
factor-α,
interleukin
(IL)-1β,
IL-6,
monocyte
chemoattractant
protein-1,
F4/80,
intercellular
adhesion
molecule-1,
vascular
cell
molecule-1.
also
considerably
ameliorated
fibrosis
regulating
suppressor
mothers
decapentaplegic/matrix
metalloproteinase
signaling.
Furthermore,
protected
senescence
protein
p53,
p16,
p21
induced
CKD.
supplementation
suppressed
CKD-induced
ferroptosis
ferritinophagy
SLC7A11
glutathione
peroxidase
4,
prostaglandin-endoperoxide
synthase
2,
human
palmitoyl-CoA
ligase,
NADPH
oxidase
4-hydroxynonenal,
transferrin
receptor,
heme
oxygenase-1,
nuclear
receptor
coactivator
beclin-1,
microtubule-associated
proteins
1A/1B
light
chain
3B,
kallikrein-related
peptidase
4.
In
conclusion,
this
suggests
may
be
potential
functional
food,
pharmaceutical,
or
can
help
regulate
mechanisms
associated
with
health.
Language: Английский
TGF-β1 induces ROS to activate ferroptosis via the ERK1/2-WISP1 pathway to promote the progression of renal tubular epithelial cell fibrosis
Yi Zhou,
No information about this author
Fengwu Luan,
No information about this author
Xiaonan Feng
No information about this author
et al.
Cytotechnology,
Journal Year:
2025,
Volume and Issue:
77(2)
Published: Feb. 14, 2025
Language: Английский
Ferroptosis and renal fibrosis: mechanistic insights and emerging therapeutic targets
Guangna Lyu,
No information about this author
Hui Liao,
No information about this author
Rongshan Li
No information about this author
et al.
Renal Failure,
Journal Year:
2025,
Volume and Issue:
47(1)
Published: May 6, 2025
Ferroptosis
is
a
regulated,
iron-dependent
form
of
cell
death
driven
by
lipid
peroxidation
and
distinct
from
apoptosis,
necroptosis,
pyroptosis.
Recent
studies
implicate
ferroptosis
as
central
contributor
to
the
pathogenesis
renal
fibrosis,
hallmark
chronic
kidney
disease
associated
with
high
morbidity
progression
end-stage
failure.
This
review
synthesizes
current
evidence
linking
ferroptotic
signaling
fibrotic
remodeling
in
kidney,
focusing
on
iron
metabolism
dysregulation,
glutathione
peroxidase
4
(GPX4)
inactivation,
peroxide
accumulation,
ferroptosis-regulatory
pathways
such
FSP1-CoQ10-NAD(P)H
GCH1-BH4.
We
detail
how
tubular
epithelial
cells
modulates
pro-fibrotic
cytokine
release,
macrophage
recruitment,
TGF-β1-driven
extracellular
matrix
deposition.
Moreover,
we
explore
therapeutic
vulnerability
highlighting
promising
agents
including
chelators,
GPX4
activators,
anti-lipid
peroxidants,
exosome-based
gene
delivery
systems.
By
consolidating
emerging
preclinical
data,
this
provides
comprehensive
mechanistic
framework
identifies
translational
opportunities
for
targeting
disease.
Language: Английский